Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adoptive Cellular Therapy”

417 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 417 results

Testing effectiveness (Phase 2)Looking for participantsNCT03645928
What this trial is testing

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

Who this might be right for
Metastatic MelanomaSquamous Cell Carcinoma of the Head and NeckNon-small Cell Lung Cancer
Iovance Biotherapeutics, Inc. 245
Testing effectiveness (Phase 2)Ended earlyNCT00924001
What this trial is testing

Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma

Who this might be right for
MelanomaMalignant MelanomaMelanoma, Experimental
National Cancer Institute (NCI) 1
Early research (Phase 1)Study completedNCT04052334
What this trial is testing

Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue Sarcoma

Who this might be right for
Sarcoma
H. Lee Moffitt Cancer Center and Research Institute 9
Early research (Phase 1)Looking for participantsNCT04020575
What this trial is testing

Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)

Who this might be right for
Metastatic Breast Cancer
Minerva Biotechnologies Corporation 69
Not applicableWithdrawnNCT03341364
What this trial is testing

Acceptance and Commitment Based Group Therapy for Cancer Patients

Who this might be right for
CancerPsychological Distress
Region Skane
Very early researchLooking for participantsNCT05141474
What this trial is testing

Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) Therapy in Advanced Epithelial Tumors and Immune Checkpoint Blockade (ICB) Resistant Solid Tumors

Who this might be right for
Epithelial Tumors, MalignantMalignant Solid Tumor
Vall d'Hebron Institute of Oncology 10
Very early researchLooking for participantsNCT05831033
What this trial is testing

Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients with Advanced Solid Tumors

Who this might be right for
Solid Tumor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT04571138
What this trial is testing

A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
Seattle Children's Hospital 42
Not applicableStudy completedNCT00001353
What this trial is testing

Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableNo Longer AvailableNCT01005537
What this trial is testing

Cyclophosphamide, Autologous Lymphocytes, and Aldesleukin in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Fred Hutchinson Cancer Center
Early research (Phase 1)Ended earlyNCT02070406
What this trial is testing

Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Jonsson Comprehensive Cancer Center 4
Early research (Phase 1)Study completedNCT00110578
What this trial is testing

Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableActive Not RecruitingNCT04911478
What this trial is testing

Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells

Who this might be right for
Lymphoma, FollicularLymphoma, Mantle-CellMarginal Zone Lymphoma+3 more
Adicet Therapeutics 50
Early research (Phase 1)Study completedNCT02588612
What this trial is testing

Letetresgene Autoleucel Engineered T Cells in NY-ESO -1 Positive Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Neoplasms
GlaxoSmithKline 10
Early research (Phase 1)Study completedNCT00101257
What this trial is testing

Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPeritoneal Cavity Cancer
Fred Hutchinson Cancer Center 18
Early research (Phase 1)Active Not RecruitingNCT02862275
What this trial is testing

Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMetastatic Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT01993719
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
National Cancer Institute (NCI) 33
Early research (Phase 1)Ended earlyNCT03396575
What this trial is testing

Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I)

Who this might be right for
Diffuse Intrinsic Pontine Glioma (DIPG)Brain Stem Glioma
University of Florida 11
Early research (Phase 1)Ended earlyNCT03266692
What this trial is testing

Study of ACTR087 in Combination With SEA-BCMA in Subjects With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple MyelomaMultiple Myeloma in RelapseRefractory Multiple Myeloma
Cogent Biosciences, Inc. 15
Testing effectiveness (Phase 2)Ended earlyNCT00871689
What this trial is testing

Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML

Who this might be right for
Leukemia
Masonic Cancer Center, University of Minnesota 2
Load More Results